WhalMyungSu, 129 Years Later, Targets Global Market with U.S. Launch of 'K.O.D'

Dongwha Pharm is taking its 129-year-old digestive medicine, WhalMyungSu, global with the launch of a new product, 'WhalMyungSu1897' (K.O.D).

The company announced the release of K.O.D, an international version of its iconic Korean digestive, and the selection of K-pop group Corti$ as its global ambassador. This move marks a significant step in Dongwha Pharm's strategy to expand its overseas business for WhalMyungSu, which has been sold domestically for over a century.

K.O.D has been developed with adjustments to its taste and ingredients to appeal to international consumers, while maintaining the brand's core identity. The product is set to launch in Korean pharmacies and duty-free shops this month. Starting in September, it will be available in U.S. supermarkets, pharmacies, and through Olive Young, with a dedicated K.O.D brand store planned for Amazon.

Dongwha Pharm aims to connect K.O.D with Korean cuisine through its campaign message, "A New Post-Meal Culture Enjoying K-Food." The company plans to promote the practice of consuming K.O.D after eating Korean food. Global campaign model Corti$, who recently achieved significant success on the Billboard 200 chart, will be featured in advertisements, short-form content, and behind-the-scenes videos that link music and K-Food. Pop-up events are also planned for U.S. markets.

A Dongwha Pharm representative stated, "This product offers a new post-meal experience that harmonizes with Korean food, based on WhalMyungSu's 129-year history. Together with Corti$, we will promote the message 'K-Food needs K.O.D.'"